Definium Therapeutics, Inc. (DFTX)
24.19
+0.71
(+3.02%)
USD |
NASDAQ |
May 29, 16:00
24.03
-0.16
(-0.66%)
After-Hours: 20:00
Definium Therapeutics Total Liabilities (Quarterly) : 122.44M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.31M |
| CNBX Pharmaceuticals, Inc. | 2.548M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 260.70M |
| Fulcrum Therapeutics, Inc. | 13.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 401.29M |
| Shareholders Equity (Quarterly) | 278.85M |
| Debt to Equity Ratio | 0.1462 |
| Current Ratio | 4.692 |
| Net Debt Paydown Yield | -0.19% |